Fibronectin-α4β1 interactions in hepatic cold ischemia and reperfusion injury: Regulation of MMP-9 and MT1-MMP via the p38 MAPK pathway

American Journal of Transplantation

Volumn 12, Issue 10, 2012, Pages 2689-2699

  Duarte, S ^a   Shen, X D ^a   Fondevila, C ^a   Busuttil, R W ^a   Coito, A J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

fibronectin; leukocyte migration; liver cold ischemia and reperfusion injury; matrix metalloproteinases

Indexed keywords

AMINOTRANSFERASE; CONNECTING SEGMENT 1 PEPTIDE; CYCLOOXYGENASE 2; FIBRONECTIN; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; MATRIX METALLOPROTEINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; COLD ISCHEMIA; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; LEUKOCYTE MIGRATION; LIVER INJURY; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SURVIVAL RATE;

ANIMALS; CYCLOOXYGENASE 2; CYTOKINES; ENZYME INDUCTION; FIBRONECTINS; IMMUNOHISTOCHEMISTRY; INTEGRIN ALPHA4BETA1; LIVER; MALE; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASE 9; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84867097420     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04161.x     Document Type: Article

References (52)

1. Selzner N, Rudiger H, Graf R, Clavien PA,. Protective strategies against ischemic injury of the liver. Gastroenterology 2003; 125: 917-936.
2. Busuttil RW, Tanaka K,. The utility of marginal donors in liver transplantation. Liver Transplant 2003; 9: 651-663.
3. Carman CV, Springer TA,. Trans-cellular migration: Cell-cell contacts get intimate. Curr Opin Cell Biol 2008; 20: 533-540.
4. Jaeschke H, Hasegawa T,. Role of neutrophils in acute inflammatory liver injury. Liver Int 2006; 26: 912-919.
5. Coito AJ,. Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury. Curr Opin Organ Transplant 2011; 16: 34-40.
6. Bianchi E, Bender JR, Blasi F, Pardi R,. Through and beyond the wall: Late steps in leukocyte transendothelial migration. Immunol Today 1997; 18: 586-591.
7. Garmy-Susini B, Avraamides CJ, Schmid MC, et al,. Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis. Cancer Res 2010; 70: 3042-3051.
8. Lefebvre JS, Levesque T, Picard S, et al,. Extra domain A of fibronectin primes leukotriene biosynthesis and stimulates neutrophil migration through activation of Toll-like receptor 4. Arthritis Rheum 2011; 63: 1527-1533.
9. van Horssen J, Dijkstra CD, de Vries HE,. The extracellular matrix in multiple sclerosis pathology. J Neurochem 2007; 103: 1293-1301.
10. Coito AJ, Brown LF, Peters JH, Kupiec-Weglinski JW, van de Water L,. Expression of fibronectin splicing variants in organ transplantation: A differential pattern between rat cardiac allografts and isografts. Am J Pathol 1997; 150: 1757-1772.
11. Pulido R, Elices MJ, Campanero MR, et al,. Functional evidence for three distinct and independently inhibitable adhesion activities mediated by the human integrin VLA-4. Correlation with distinct alpha 4 epitopes. J Biol Chem 1991; 266: 10241-10245.
12. O'Connor P,. Natalizumab and the role of alpha 4-integrin antagonism in the treatment of multiple sclerosis. Expert Opin Biol Ther 2007; 7: 123-136.
13. Fiorino G, Correale C, Fries W, Repici A, Malesci A, Danese S,. Leukocyte traffic control: A novel therapeutic strategy for inflammatory bowel disease. Expert Rev Clin Immunol 2010; 6: 567-572.
14. Coito AJ, de Sousa M, Kupiec-Weglinski JW,. Fibronectin in immune responses in organ transplant recipients. Dev Immunol 2000; 7: 239-248.
15. Man S, Tucky B, Bagheri N, Li X, Kochar R, Ransohoff RM,. alpha4 Integrin/FN-CS1 mediated leukocyte adhesion to brain microvascular endothelial cells under flow conditions. J Neuroimmunol 2009; 210: 92-99.
16. Perez VA, Ali Z, Alastalo TP, et al,. BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt pathways. J Cell Biol 2011; 192: 171-188.
17. Amersi F, Shen XD, Moore C, et al,. Fibronectin-alpha 4 beta 1 integrin-mediated blockade protects genetically fat Zucker rat livers from ischemia/reperfusion injury. Am J Pathol 2003; 162: 1229-1239.
18. Moore C, Shen XD, Gao F, Busuttil RW, Coito AJ,. Fibronectin-alpha4beta1 integrin interactions regulate metalloproteinase-9 expression in steatotic liver ischemia and reperfusion injury. Am J Pathol 2007; 170: 567-577.
19. Kamada N, Davies HS, Wight D, Culank L, Roser B,. Liver transplantation in the rat. Biochemical and histological evidence of complete tolerance induction in non-rejector strains. Transplantation 1983; 35: 304-311.
20. Fondevila C, Shen XD, Tsuchiyashi S, et al,. Biliverdin therapy protects rat livers from ischemia and reperfusion injury. Hepatology 2004; 40: 1333-1341.
21. Hamada T, Fondevila C, Busuttil RW, Coito AJ,. Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury. Hepatology 2008; 47: 186-198.
22. Kuriyama N, Duarte S, Hamada T, Busuttil RW, Coito AJ,. Tenascin-C: A novel mediator of hepatic ischemia and reperfusion injury. Hepatology 2011; 54: 2125-2136.
23. Hamada T, Duarte S, Tsuchihashi S, Busuttil RW, Coito AJ,. Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury. Am J Pathol 2009; 174: 2265-2277.
24. Kim SF, Huri DA, Snyder SH,. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. Science 2005; 310: 1966-1970.
25. Hamada T, Tsuchihashi S, Avanesyan A, et al,. Cyclooxygenase-2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/reperfusion injury. J Immunol 2008; 180: 1843-1853.
26. Matias-Roman S, Galvez BG, Genis L, et al,. Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood 2005; 105: 3956-3964.
27. Johnson GL, Lapadat R,. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002; 298: 1911-1912.
28. Shankavaram UT, Lai WC, Netzel-Arnett S, et al,. Monocyte membrane type 1-matrix metalloproteinase. Prostaglandin-dependent regulation and role in metalloproteinase-2 activation. J Biol Chem 2001; 276: 19027-19032.
29. Montalvo-Jave EE, Escalante-Tattersfield T, Ortega-Salgado JA, Pina E, Geller DA,. Factors in the pathophysiology of the liver ischemia-reperfusion injury. J Surg Res 2008; 147: 153-159.
30. Pankov R, Yamada KM,. Fibronectin at a glance. J Cell Sci 2002; 115: 3861-3863.
31. Wierzbicka-Patynowski I, Schwarzbauer JE,. The ins and outs of fibronectin matrix assembly. J Cell Sci 2003; 116: 3269-3276.
32. Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM,. Expression of variant fibronectins in wound healing: Cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol 1994; 127: 2037-2048.
33. George J, Wang SS, Sevcsik AM, et al,. Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform. Am J Pathol 2000; 156: 115-124.
34. Muro AF, Chauhan AK, Gajovic S, et al,. Regulated splicing of the fibronectin EDA exon is essential for proper skin wound healing and normal lifespan. J Cell Biol 2003; 162: 149-160.
35. Wynn TA,. Integrating mechanisms of pulmonary fibrosis. J Exp Med 2011; 208: 1339-1350.
36. Bissell DM,. Hepatic fibrosis as wound repair: A progress report. J Gastroenterol 1998; 33: 295-302.
37. Muro AF, Moretti FA, Moore BB, et al,. An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med 2008; 177: 638-645.
38. Le Moine O, Louis H, Demols A, et al,. Cold liver ischemia-reperfusion injury critically depends on liver T cells and is improved by donor pretreatment with interleukin 10 in mice. Hepatology 2000; 31: 1266-1274.
39. Gao B, Jeong WI, Tian Z,. Liver: An organ with predominant innate immunity. Hepatology 2008; 47: 729-736.
40. Ozturk H, Gezici A,. The effect of celecoxib, a selective COX-2 inhibitor, on liver ischemia/reperfusion-induced oxidative stress in rats. Hepatol Res 2006; 34: 76-83.
41. Moon KH, Hood BL, Mukhopadhyay P, et al,. Oxidative inactivation of key mitochondrial proteins leads to dysfunction and injury in hepatic ischemia reperfusion. Gastroenterology 2008; 135: 1344-1357.
42. Sternlicht MD, Werb Z,. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463-516.
43. Perentes JY, Kirkpatrick ND, Nagano S, et al,. Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors. Cancer Res 2011; 71: 4527-4538.
44. Seiki M,. Membrane-type 1 matrix metalloproteinase: A key enzyme for tumor invasion. Cancer Lett 2003; 194: 1-11.
45. Moss NM, Wu YI, Liu Y, Munshi HG, Stack MS,. Modulation of the membrane type 1 matrix metalloproteinase cytoplasmic tail enhances tumor cell invasion and proliferation in three-dimensional collagen matrices. J Biol Chem 2009; 284: 19791-19799.
46. Wynn TA, Barron L,. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010; 30: 245-257.
47. Mainiero F, Gismondi A, Soriani A, et al,. Integrin-mediated ras-extracellular regulated kinase (ERK) signaling regulates interferon gamma production in human natural killer cells. J Exp Med 1998; 188: 1267-1275.
48. Ono K, Han J,. The p38 signal transduction pathway: Activation and function. Cell Signal 2000; 12: 1-13.
49. King LA, Toledo AH, Rivera-Chavez FA, Toledo-Pereyra LH,. Role of p38 and JNK in liver ischemia and reperfusion. J Hepatobiliary Pancreat Surg 2009; 16: 763-770.
50. Li H, Mittal A, Paul PK, et al,. Tumor necrosis factor-related weak inducer of apoptosis augments matrix metalloproteinase 9 (MMP-9) production in skeletal muscle through the activation of nuclear factor-kappaB-inducing kinase and p38 mitogen-activated protein kinase: A potential role of MMP-9 in myopathy. J Biol Chem 2009; 284: 4439-4450.
51. Kumar B, Koul S, Petersen J, et al,. p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity. Cancer Res 2010; 70: 832-841.
52. Braz JC, Bueno OF, Liang Q, et al,. Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling. J Clin Invest 2003; 111: 1475-1486.